Picture of Kissei Pharmaceutical logo

4547 — Kissei Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Kissei Pharm - 9-MTH group results

Feb 1 (Reuters)- 
             Kissei Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             50.09               52.20            65.40    
                 (-4.0 pct)          (+7.5 pct)       (-5.3 pct)  
  Operating     loss 294 mln             3.19          loss 1.60  
                                     (+16.5 pct)                  
  Recurring          1.35                4.57           300 mln   
                 (-70.4 pct)         (+19.3 pct)      (-91.4 pct) 
  Net                6.82                6.44            11.90    
                 (+5.9 pct)          (+81.8 pct)     (+125.2 pct) 
  EPS            147.87 yen          137.86 yen       258.05 yen  
  Ann Div                             54.00 yen        56.00 yen  
  -Q2 div         28.00 yen           27.00 yen                   
  -Q4 div                             27.00 yen        28.00 yen  
  
  NOTE - Kissei Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T

Recent news on Kissei Pharmaceutical

See all news